Home
Photo of Thomas Schön

Thomas Schön

Professor

My research concerns individualized treatment and improved diagnostics for tuberculosis and other infectious diseases.

Research focused on tuberculosis

My research is mainly focused on tuberculosis which causes about 10 million new cases per year of which about 1 million die. The immune system, bacterial resistance mechanisms to treatment and antibiotic dosing are important factors that partly determine who gets sick and who does not, but also how successful the treatment will be.

Several of my research projects in both Sweden and Ethiopia concern individualized treatment and improved diagnostics for tuberculosis and other infectious diseases, with the aim of improving the resilience of the immune system and streamlining treatment.

News

Toomas Timpka.

No association between COVID-vaccine and decrease in childbirth

COVID-19 vaccination is not the cause behind a decrease in childbirth, according to a study from Linköping University. The results speak against rumours about vaccination and reduced fertility.
vaccination.

SEK 15 million for research into Covid-19 vaccination

A research project coordinated by LiU has been awarded more than SEK 15 million by the Swedish Research Council to evaluate vaccination against Covid-19.

Publications

Latest publications in LiU DiVA

2026

Daniel Augustinsson, Ayu Sakao, Mårten Sandstedt, A. Getachew, Jonna Idh, E. Abate, Sven Göran Fransson, Katarina Niward, Thomas Schön (2026) Computer-aided detection of chest X-ray as a surrogate marker for disease severity in pulmonary TB The International Journal of Tuberculosis and Lung Disease, Vol. 30, p. 187-189 (Article in journal) Continue to DOI
Jan-Willem C Alffenaar, Sophie L Stocker, Thomas Schön (2026) Does One Dose Fit All in Tuberculosis Meningitis Treatment? Journal of Infectious Diseases (Article in journal) Continue to DOI
Josephine Gal, Martina Sönnerbrandt, Clara Braian, Thomas Schön, Robert Blomgran (2026) Differential regulation of monocyte oxidative burst by isoniazid in healthy and latent tuberculosis-infected subjects Frontiers in Pharmacology, Vol. 17, Article 1763287 (Article in journal) Continue to DOI
Tobias Damgaard, Thomas Hellborg, Anders Larsson, Erik Eliasson, Jonas Bonnedahl, Elisabet I Nielsen, Thomas Schön, Anita Hällgren (2026) Unbound cloxacillin plasma concentrations in relation to toxicity and renal function: protocol for a prospective, observational clinical trial in a real-world Staphylococcus aureus bacteraemia population BMJ Open, Vol. 16, Article e109745 (Article in journal) Continue to DOI
Marie Buysse, Matthew J. Ballinger, Marjorie Bruley, Julien Amoros, Justine Grillet, Navid Farassat, Annerose Serr, Wolf Alexander Lagreze, Christine Wenneras, Anna Grankvist, Thomas Schön, Jonas Berglund, Lesley Bell-Sakyi, Hein Sprong, Olivier Duron (2026) A human-associated Spiroplasma ixodetis lineage responsible for infantile cataracts and adult febrile illness iScience, Vol. 29, Article 115233 (Article in journal) Continue to DOI

Research

A doctor looks at X-rays.

Individualised diagnosis and treatment of tuberculosis

Our general aim is to individualise and thereby optimize management of clinical TB by new methods and strategies. The research group consists of specialists in tuberculosis from different professions.

Organisation

Teaser image for the division II at BKV.

Division of Inflammation and Infection (II)

The Division of Inflammation and Infection (II) includes clinical subject areas such as Immunology, Rheumatology, Pathology and Microbiology.

Department of Biomedical and Clinical Sciences (BKV)

What characterizes the Department of Biomedical and Clinical Sciences (BKV) is the wide breadth of research and education. BKV is one of the largest departments at LiU with affiliation mainly to the Faculty of Medicine and Health Sciences.

Tags